A detailed history of Cutter & CO Brokerage, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 4,443 shares of GILD stock, worth $411,288. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,443
Previous 4,296 3.42%
Holding current value
$411,288
Previous $294,000 26.53%
% of portfolio
0.09%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$66.59 - $83.99 $9,788 - $12,346
147 Added 3.42%
4,443 $372,000
Q2 2024

Jul 31, 2024

BUY
$63.15 - $72.88 $7,262 - $8,381
115 Added 2.75%
4,296 $294,000
Q1 2024

Apr 30, 2024

BUY
$71.58 - $87.29 $572 - $698
8 Added 0.19%
4,181 $306,000
Q4 2023

Feb 01, 2024

BUY
$73.27 - $83.09 $13,188 - $14,956
180 Added 4.51%
4,173 $338,000
Q3 2023

Oct 31, 2023

BUY
$73.94 - $80.67 $443 - $484
6 Added 0.15%
3,993 $299,000
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $39,449 - $44,997
519 Added 14.97%
3,987 $307,000
Q1 2023

May 09, 2023

BUY
$77.31 - $88.08 $4,870 - $5,549
63 Added 1.85%
3,468 $287,000
Q4 2022

Feb 03, 2023

BUY
$62.32 - $89.47 $212,199 - $304,645
3,405 New
3,405 $292,000
Q1 2019

Apr 23, 2019

SELL
$62.53 - $70.05 $351,793 - $394,101
-5,626 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$60.54 - $79.0 $880,554 - $1.15 Million
-14,545 Reduced 72.11%
5,626 $352,000
Q3 2018

Oct 12, 2018

SELL
$71.28 - $78.92 $55,170 - $61,084
-774 Reduced 3.7%
20,171 $1.56 Million
Q2 2018

Jul 30, 2018

SELL
$64.88 - $75.68 $40,679 - $47,451
-627 Reduced 2.91%
20,945 $1.48 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $77,720 - $94,749
1,067 Added 5.2%
21,572 $1.63 Million
Q4 2017

Jan 30, 2018

SELL
$71.15 - $83.52 $70,438 - $82,684
-990 Reduced 4.61%
20,505 $1.47 Million
Q3 2017

Oct 23, 2017

SELL
$72.11 - $85.47 $28,844 - $34,188
-400 Reduced 1.83%
21,495 $1.74 Million
Q2 2017

Aug 07, 2017

BUY
N/A
21,895
21,895 $1.55 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.